Blinatumomab is an anti-CD19/anti-CD3 bi-specific T cell engager.
SparkCures ID | 362 |
---|---|
Brand Name | Blincyto® |
Generic Name | Blinatumomab |
Treatment Classifications | |
Treatment Targets |
|
There are no resources, links or videos to display for this treatment.